Скачайте изображение (превью) выбрав качество

320x180 480x360 640x480 1280x720

Visit Radcliffe Cardiology:

Dr Marc Bonaca (University of Colorado School of Medicine, Aurora, Colorado, US) joins us to discuss the findings of the BT001 Pivotal Trial, originally presented at AHA 2022.

BT001 Pivotal aimed to study the use of a mobile app that delivered nutritional cognitive behavioural therapy (nCBT) for the treatment of type II diabetes. The application targets behaviours which are associated with achieving glycaemic control. The treatment was compared to standard care across over 600 patients, randomised on a 1:1 basis.

Questions:
1. Please outline the device studied in this trial
2. What was the patient population and study design?
3. What are your key findings?
4. How could the findings of this trial impact clinicians' daily practice?
5. What are your take-home messages?
6. What are the future directions for this technology?

Recorded remotely from Colorado, 2022.
This content is intended for healthcare professionals only.

Radcliffe brings medical knowledge, insight and innovation to life for CV clinicians around the world, using our communications & creative expertise, our platforms and connections across the community to help transform theory into practice faster.

Чтобы скачать видео "AHA 22: BT001 PIVOTAL: nCBT in Pts with Type II Diabetes | Dr Marc Bonaca" передвинте ползунок вправо